BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7331894)

  • 1. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
    Böttiger LE; Böttiger B
    Acta Med Scand; 1981; 210(6):475-9. PubMed ID: 7331894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced blood dyscrasias in Sweden.
    Böttiger LE; Westerholm B
    Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study.
    Maluf E; Hamerschlak N; Cavalcanti AB; Júnior AA; Eluf-Neto J; Falcão RP; Lorand-Metze IG; Goldenberg D; Santana CL; Rodrigues Dde O; Passos LN; Rosenfeld LG; Pitta M; Loggetto S; Ribeiro AA; Velloso ED; Kondo AT; Coelho EO; Pintão MC; de Souza HM; Borbolla JR; Pasquini R
    Haematologica; 2009 Sep; 94(9):1220-6. PubMed ID: 19734415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative incidence of agranulocytosis and aplastic anemia.
    Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
    Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study.
    Hamerschlak N; Maluf E; Pasquini R; Eluf-Neto J; Moreira FR; Cavalcanti AB; Okano IR; Falcão RP; Pita MT; Loggetto SR; Rosenfeld LG; Lorand-Metze IG
    Sao Paulo Med J; 2005 May; 123(3):101-4. PubMed ID: 16021270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
    Rawson NS; Harding SR; Malcolm E; Lueck L
    J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study.
    Blood; 1987 Dec; 70(6):1718-21. PubMed ID: 3676511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematological reactions.
    Huguley CM
    JAMA; 1966 May; 196(5):408-10. PubMed ID: 5952218
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
    Levy M; Kelly JP; Kaufman DW; Shapiro S
    Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].
    TRAISSAC FJ; BERAUD C; DANGOUMAU J
    Bull World Health Organ; 1964; 31(1):95-100. PubMed ID: 14230898
    [No Abstract]   [Full Text] [Related]  

  • 14. Agranulocytosis and aplastic anemia among Ramathibodi Hospital patients.
    Jootar S; Chaisiripoomkere W; Rojanasthien S
    J Med Assoc Thai; 1992 Sep; 75(9):514-6. PubMed ID: 1304020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality resulting from blood dyscrasias in the United States, 1984.
    Hine LK; Gerstman BB; Wise RP; Tsong Y
    Am J Med; 1990 Feb; 88(2):151-3. PubMed ID: 2301442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRUG-INDUCED BLOOD DYSCRASIAS.
    HUGULEY CM
    Dis Mon; 1963 Oct; 24():1963:1-52. PubMed ID: 14051625
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-associated blood dyscrasias. Recent additions to the Registry.
    BEST WR
    JAMA; 1963 Jul; 185():286-90. PubMed ID: 13967788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug hypersensitivity].
    Cruchaud S; Frei PC
    Schweiz Med Wochenschr; 1967 Nov; 97(47):1568-71. PubMed ID: 5596884
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
    Kelly JP; Kaufman DW; Shapiro S
    Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.